Facebook Linkedin Mail Twitter
Facebook Linkedin Mail Twitter

Tag: FREEDOM-1

Talaris announces positive kidney graft acceptance findings from FREEDOM-1 study

Talaris Therapeutics today provided a clinical update on its ongoing phase 3 FREEDOM-1 study of FCR001—the company's investigational allogeneic cell therapy designed to induce...
Renal Interventions

Write to us
Editor: George Barker [email protected]
Advertising: Rav Pankhania [email protected]


United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Facebook Linkedin Mail Twitter